Effects of cannabinoids on colonic muscle contractility and tension in guinea pigs

Journal of Nippon Medical School

Volumn 72, Issue 1, 2005, Pages 43-51

  Harada, Naoshige ^a   Nemoto, Kayo ^a   Okamura, Tadao ^a   Ninomiya, Norifumi ^a,b   Suzuki, Hidenori ^a   Yamamoto, Yasuhiro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Cannabinoids; CB1 recepter; Colon; Contractility; Guinea pig; Tension

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CALCIUM; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CHARYBDOTOXIN; POTASSIUM CHANNEL BLOCKING AGENT; 2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; ARACHIDONIC ACID DERIVATIVE; ENDOCANNABINOID; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CECUM TENIA; COLON; COLON MOTILITY; CONTROLLED STUDY; ELECTROSTIMULATION; EXPERIMENT; FORCE TRANSDUCER; GUINEA PIG; IN VITRO STUDY; IN VIVO STUDY; INJECTION; INTESTINE; INTESTINE MUSCLE; ISOLATED ORGAN; MALE; MONITORING; MUSCLE CONTRACTILITY; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE TONE; NONHUMAN; PERISTALSIS; PROSPECTIVE STUDY; TELEMETRY; TIME; ANIMAL; BODY TEMPERATURE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GASTROINTESTINAL MOTILITY; PHYSIOLOGY;

ANIMALS; ARACHIDONIC ACIDS; BODY TEMPERATURE; CANNABINOIDS; COLON; ELECTRIC STIMULATION; ENDOCANNABINOIDS; GASTROINTESTINAL MOTILITY; GLYCERIDES; GUINEA PIGS; MALE; MORPHOLINES; MUSCLE CONTRACTION; NAPHTHALENES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1;

EID: 21844451672     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.72.43     Document Type: Article

References (16)

1. Marik PE, Varon J: Sepsis: Intensive care medicine (Irwin RS, Rippe JM, eds), Fifth Edition, 2003; pp 1822-1833, Lippincott Williams & Wilkins, Philadelphia.
2. Bauer AJ, Schwartz NT, Moore BA, Turler A, Kalff JC: Ileus in critical illness: mechanisms and management. Current Opinion in Critical Care 2002; 8: 152-158.
3. Wang Y, Liu Y, Ito Y, Hashiguchi T, Kitajima I, Yamaguchi M, Shimizu H, Matsuo S, Imaizumi H, Marukawa I: Simultaneous measurement of anandamide and arachidonoylglycerol by polimyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: Increase in endogenous cannabinoids in the sera of patients with end toxic shock. Analytical Biochemistry 2001; 294: 73-82.
4. Coutts AA, Pertwee RG: Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus. Br J Pharmacol 1997; 121: 1557-1566.
5. Izzo AA, Mascolo N, Borrelli F, Capasso F: Excitatory transmission to the circular muscle of the guinea-pig ileum: Evidence for the involvement of cannabinoid CB1 receptor. Br J Pharmacol 1998; 124: 1363-1368.
6. Pinto L, Izzo AA, Cascio MG, Bisogno T, Hospodar-Scott K, Brown DR, Mascolo N, DI Marzo V, Caposso F: Endocannabinoids as physiological regulators of colonoc propulsion in mice. Gastroenterology 2002; 123: 227-234.
7. Ninomiya N, Nemoto K, Okamura T, Yamamoto Y: Suppression of guinea pig intestinal tract contraction by lipopolysaccharide. J Jap Assoc Acute Med 2000; 11: 651-659.
8. Ninomiya N, Nemoto K, Okamura T, Suzuki H, Yamamoto Y: A novel experimental method for the study of intestinal paralysis due to endotoxicosis. J Jap Assoc Acute Med 2003; 14: 241-250.
9. Storr M, Sibaev A, Marsciano G, Lutz B, Schusdziarra V, Timmermans JP, Allescher HD: Cannabinoid recepter type 1 modulates exciatory and inhibitory neurotransmission in mouse colon. AJP Gastrointest Liver Physiol 2004; 286: 110-117.
10. Lopez-Redondo F, Lees, GM, Pertwee RG: Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guinea-pig ileum. Br J Pharmacol 1997; 122: 330-384.
11. Pertwee RG, Fernand SR, Nash JE, Coutts AA: Further evidence for the presence of cannabinoid CB1 recepters in guina-pig small intestine. Br J Pharmacol 1996; 118: 2199-2205.
12. +current. J of biol chemistry 2003; 278: 46188-46194.
13. Jarai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, Razdan RK, Zimmer A, Kunos G: Cannabinoid-induced mesenteric vasodilatation through an endothelial site distinct from CB1 or CB2 receptor. Proc Natl Acad Sci 1999; 96: 14136-14141.
14. Plane F, Holland M, Walderon GJ, Garland CJ, Boyle JP: Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries. Br J Pharmacol 1997; 121: 1509-1511.
15. Ralevic V: Cannabinoid modulation of peripheral autonomic and sensory neurotransmission. Euro J of pharmacol 2003; 472: 1-21.
16. Rawls SM, Cabassa J, Geller EB, Adler MW: CB1 receptor in the preoptic anterior hypothalamus regulate WIN55212-2 [(4, 5-dihydro-2-methyl-4-(4- morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6 H-pyrrolo [3,2,1ij] quinolin-6-one) -induced hypothermia. J Pharmacol Exp Ther 2002; 301: 963-968.